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Abstract: The diverse and magnificent plant kingdom of the world is widely known for its medicinal importance. The potential medicinal
properties of plant species have contributed significantly in the development of various herbal therapies for a number of diseases across
the globe. The benefits of herbal medicine over allopathic medicine have helped medicinal plants to regain their importance in the field
of health and medicine. Cancer is one of the major health problems that have widely affected the world’s population. There is a great
need to combat this disease with better and more effective medication as compared to existing therapies. A vast number of medicinal
plants are known to have biochemical constituents with anticancer properties. The chemical metabolites of natural origin that possess
anticancer properties can serve as potential lead compounds in drug designing. This association of medicinal plants and cancer needs
further research and experimentation in order to develop and design anticancer drugs. The present review is an effort to compile
information on some of the geographically diverse and important medicinal plants that possess anticancer activity.
Key words: Biochemical constituent, anticancer properties, medicinal plants, drug designing, antiinflammatory, antiviral, antitumor,
antimalarial, analgesic

1. Introduction
Medicinal plants are considered a repository of numerous
types of bioactive compounds possessing varied
therapeutic properties. The therapeutic potential of plants
has been well explored over a very long time period. The
vast array of therapeutic effects associated with medicinal
plants includes antiinflammatory, antiviral, antitumor,
antimalarial, and analgesic. Cancer is one of the major
obstacles to human health around the world. Among all
epidemic diseases, cancer holds the first place as a deathcausing disease. The main reason behind the growing
number of cancer cases is the changing lifestyle of the
population across the globe. Keeping in view the statistical
data, the most prevalent cancer among females is breast
cancer, accounting for about 23% of total cancer cases; in
males, the most prevalent is lung cancer, which accounts
for 17% of total cancer cases (Jemal et al., 2011). Poor
survival rate of cancer patients in developing countries
is attributed to the lack of timely diagnosis and limited
treatment facilities. There is a great need to address this
epidemic disease with more effective therapeutic and
preventive strategies, which could be possible with the use
of natural compounds.
Recently the scientific world has experienced an
upsurge of interest in the therapeutic potential of medicinal
* Correspondence: navneetab@dtu.co.in

plants as a source of promising anticancer agents. However,
the application of plant-based compounds for the treatment
of cancer can be traced back to 1950s. Some of the very first
anticancer agents derived from plants are vinca alkaloids,
vinblastine, vincristine, and cytotoxic podophyllotoxins.
Statistical data suggest that 16 plant-derived anticancer drugs
have been subjected to clinical trials thus far (Belayachi et
al., 2013). Landmarks of these clinical trials are flavopiridol,
isolated from the Indian tree Dysoxylum binectariferum,
and meisoindigo, isolated from the Chinese plant Indigofera
tinctoria, which have been documented to have less toxicity
than conventional chemotherapeutic anticancer drugs
(Saklani and Kutty, 2008). These discoveries have propelled
the scientific interest of various research groups in the
discovery of new anticancer agents from all-natural product
sources, inclusive of plant secondary metabolites. The
emerging importance of natural anticancer agents demands
more research and experimentation in order to develop
successful natural therapeutic options for this disease. This
review focuses on the phytochemical aspect of some of the
potential anticancer medicinal plants with data gathered
from the scientific literature of the PubMed database. Thus,
the present review aims to assemble information on some of
the medicinal plants that possess anticancer properties and
thus great potential for cancer treatment.
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2. Medicinal plants as the best choice for cancer
treatment
The chemical components of medicinal plants mainly
possess antioxidant properties that contribute to their
anticancer potential. Flavones, isoflavones, flavonoids,
anthocyanins, coumarins, lignans, catechins, and
isocatechins are the major classes of bioactive constituents
responsible for the antioxidant action (Nema et al.,
2013). The great potential of plant-based compounds for
the treatment and prevention of cancer is attributed to
their safety, low cost, and oral bioavailability. However,
a few plant-based compounds induce some side effects.
These side effects can be overcome by dose-dependent
administration and usage, and do not in any case make
them unsuitable for phytochemical research. The already
available expensive conventional therapies for cancer
like chemotherapy and radiotherapy have a number of
side effects such as myelosuppression and neurological,
cardiac, pulmonary, and renal toxicity, which pose serious
harm to the quality of life (Alonso-Castro et al., 2011).
Therefore, there is a need to develop treatment options
that include more potent and less toxic anticancer drugs
as compared to existing drugs. The market statistics
mark the availability of approximately 60% plant-based
anticancer drugs (Gordaliza, 2007). Medicinal plants
constitute a common alternative to cancer treatment in
many countries of the world (Gerson-Cwilich et al., 2006;
Tascilar et al., 2006). Cytotoxic screening of a number of
plants has been done to correlate their anticancer activity
and further expand their scope for drug development
(Akter et al., 2014). Owing to potential benefits of plantbased drugs for cancer treatment, their use is increasingly
growing from 10% to 40% across the globe; specifically,
on the Asian continent, it has reached 50% (Cassileth and
Deng, 2004; Molassiotis et al., 2006). Anticancer benefits
associated with natural plant derivatives demand extensive
scientific screening and clinical experimentations for the
development of improved drugs.
3. Medicinal plants with anticancer properties
3.1. Actaea racemosa L.
Actaea racemosa belongs to the family Ranunculaceae
and has its origin in eastern North America. Its common
names are ‘black cohosh’ and ‘black snakeroot’. The main
characteristic chemical compounds present in this plant
are cycloartenol-type triterpenoids, cimicifugoside, and
cinnamic acid derivatives. The plant is well known for its
use in conditions such as chronic ovaritis and amenorrhea
(Mahady et al., 2002). An active metabolite of this plant,
actein has been shown to inhibit the proliferation of human
breast cancer cells and human liver cancer cells (HepG2)
and thus possess antitumor activity. Actein alters the
expression of cholesterol and fatty acid biosynthetic genes,
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p53 pathway genes, CCND1, and ID3. Actein-induced
inhibition of growth of human HepG2 liver cancer cells is
because of the reduced free fatty acid and cholesterol levels
in the liver (Einbonda et al., 2009).
3.2. Allium sativum L.
Allium sativum is commonly known as garlic and
belongs to the family Liliaceae/Alliaceae. It contains
sulfur compounds, numerous enzymes, 17 amino
acids, and minerals like selenium. Garlic contains much
bioavailable selenium, which is an antioxidant and could
be chemopreventive (Ip and Lisk, 1996). It is used in the
treatment of earaches, deafness, leprosy, severe diarrhea,
fever, and stomachaches. One of its chief therapeutic
effects is to treat cardiovascular diseases by lowering blood
pressure as well as cholesterol. It also acts as an antimicrobial
and chemopreventive agent. S-Allylmercaptocysteine is
the most important antitumor constituent of aged garlic
extract. The antiproliferative effect of thioallyl compounds
has been studied in a number of cell lines and the results
have shown sensitivity of these compounds to breast and
prostate cell lines (Sigounas et al., 1997).
3.3. Andrographis paniculata Wall. ex Nees
Andrographis paniculata is a herbaceous plant that belongs
to the family Acanthaceae. It is extensively grown on the
Asian continent. It is commonly known by the names
‘king of bitters’ and ‘creat’. Four lactones, chuanxinlian
A (deoxyandrographolide), B (andrographolide),
C (neoandrographolide), and D (4-deoxy-11,12didehydroandrographolide), constitute its important
secondary metabolites. The plant possesses antibacterial,
antifungal,
antiviral,
choleretic,
hypoglycemic,
hypocholesterolemic, and adaptogenic effects (Bhatnagar
et al., 1961). Its blood-purifying property makes it a choice
for the treatment of a number of disease conditions such
as boils, skin eruptions, chronic undetermined fevers,
and scabies. The plant also contains an anticancer agent
called andrographolide, which is an antiinflammatory
diterpenoid lactone that inhibits interleukin-6 (IL-6)
expression, suppresses IL-6-mediated signals, and induces
cell apoptosis by the activation of apoptosis-related
proteins/mitogen-activated protein kinases, and thus plays
an important role as a cytotoxic agent in the case of liver
cancer (Ji et al., 2007).
3.4. Ardisia crenata Roxb.
Ardisia crenata is a member of the family Myrsinaceae,
which is mostly found in the warm climates of tropical
and subtropical regions. This plant is also known by the
names ‘coral bush’, ‘coralberry’, ‘hen’s eyes’, ‘spiceberry’,
and ‘red berries’. Numerous chemical constituents that
have been extracted and characterized from this plant
include cyclic depsipeptide, peptide, alkenylphenol, and
triterpenoid saponins (Horgen et al., 1997). It has been
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widely used as traditional medicine to cure diseases such
as pulmonary tuberculosis, hepatitis, chronic bronchitis,
and irregular menstruation. Its cytotoxic effect is attributed
to ardisiacrispin, which is a mixture of 2 triterpenoid
saponins, ardisiacrispins A and B. Experimental studies
have shown that the mixture of triterpenoid saponins
inhibits the uncontrolled proliferation of the Bel-7402 liver
cancer cell line by inducing proapoptotic and microtubule
disruptive activities (Li et al., 2008). Microtubules play an
important role in mitosis, and so targeting them yields
antiproliferative effects in cancer cells.
3.5. Boswellia serrata Roxb.
Boswellia serrata belongs to the family Burseraceae and is
extensively found in India, North Africa, and the Middle
East. Its common names include ‘Indian olibanum tree’,
‘olibanum’, ‘luban’, and ‘gond’. It contains an array of
chemical constituents like oils, terpenoids, sugars, and
volatile oils. Β-Boswellic acid is the major constituent
among 4 pentacyclic triterpene acids of this plant
(Krieglstein et. al., 2001). The plant’s gummy exudates are
associated with therapeutic effects, including astringent,
antiarthritic, expectorant, stimulant, and antiseptic
effects. Acetyl-11-keto-β-boswellic acid (AKBA), an active
component from this medicinal plant, has the ability to
strongly inhibit tumor angiogenesis induced through
vascular endothelial growth factor (VEGF) signaling.
It also inhibits multiple steps of VEGF-induced cell
proliferation, migration, invasion, and tube formation.
Studies have shown that AKBA suppressed tumor growth
in human prostate tumor xenograft mice treated daily with
a dose of 10 mg/kg after solid tumors reached ~100 mm3
(n = 5). Thus, the compound AKBA is antitumorous in
nature (Pang et al., 2009).
3.6. Catharanthus roseus (L.) G.Don
Catharanthus roseus belongs to the family Apocynaceae
and is commonly known as Madagascar periwinkle. It is
originally native to the island of Madagascar. Alkaloids,
its main chemical constituents, are employed in the
treatment of circulatory diseases, and specifically in the
relief of obstruction of normal cerebral blood flow. The
plant also possesses medicinal activities like astringent,
diuretic, and antidiabetic effects and can serve as a cold
remedy to ease lung congestion and inflammation. Two
pharmacologically active alkaloids, vinblastine and
vincristine, are well known for their significant curative
effects against human neoplasms. Vinblastine sulfate (sold
as Velban) is also employed in therapy for lymphosarcoma,
choriocarcinoma, neuroblastoma, and carcinoma of
the breasts, lungs and other organs in acute and chronic
leukemia. Vincristine sulfate (sold as Oncovin) is known
to arrest mitosis and is thus used as a treatment for
acute leukemia in children and lymphocytic leukemia.
Vincristine sulfate is also used as therapy for Hodgkin

disease, Wilkins tumor, neuroblastoma, and reticulum cell
sarcoma (Noble, 1990).
3.7. Centella asiatica L.
Centella asiatica is a small herbaceous perennial plant
and a member of the family Apiaceae. Its common names
are ‘Asiatic pennywort’ and ‘gotu kola’. The plant is native
to India, China, Indonesia, Australia, the South Pacific,
Madagascar, and South and Central Africa. Phytochemical
studies have shown the presence of glycoside asiaticoside
and asiatic and madecassic acid. Its medicinal importance
in chronic diseases has already been mentioned in the
Ayurvedic system of medicine, where it is known as a
‘brain tonic’ for various mental disorders. It is being
employed for the treatment of heatstroke, diarrhea,
ulcerations, eczema, and traumatic diseases. The presence
of asiatic acid, a pentacyclic triterpene, in this plant has
added to its medicinal importance as an anticancer agent.
The cytotoxic effect of asiatic acid has been investigated
and it has been shown to decrease the viability of HepG2
cells in the case of liver cancer. The decrease in cell viability
is due to increased expression of a tumor-suppressor p53
gene mediated by increased levels of intracellular calcium
(Lee et al., 2002).
3.8. Curcuma longa L.
Curcuma longa belongs to the family Zingiberaceae and
is widely grown in Asiatic countries, mainly in India and
China. It is commonly known as turmeric. Biliary disorders,
anorexia, coryza, cough, diabetic wounds, hepatic disorder,
rheumatism, and sinusitis are some of the conditions
for which the plant has shown its medicinal properties
(Ammon et al., 1992). An array of pharmacological
activities of this plant includes antiinflammatory,
antihuman immunodeficiency virus, antibacterial, and
antioxidant effects and nematicidal activities. Its major
chemical constituent is curcumin and it exhibits numerous
biological actions. The curcumin compound also exhibits
antitumor potential via suppression of the various events
involved in multiple steps of carcinogenesis such as
transcription factor, NF-κB, AP-1, and STAT-3 and the
ability to repress proinflammatory pathways of COX-2 and
iNOS (Plengsuriyakarn et al., 2012).
3.9. Fagara zanthoxyloides L.
Fagara zanthoxyloides belongs to the family Rutaceae,
widely distributed in Uganda and other African countries.
It is commonly known by the name ‘candlewood’. Rootbark extract is used in treating elephantiasis, toothache,
sexual impotence, gonorrhea, malaria, dysmenorrhea,
and abdominal pain. The benzophenanthridine alkaloid
fagaronine exhibits antitumor activity against P388 and
L1210 murine leukemic cell lines in vivo. Fagaronine
inhibits the DNA replication of rapidly growing cancer
cells by inhibiting DNA and RNA polymerase activities

1029

RAINA et al. / Turk J Bot
and protein synthesis. Fagaronine leads to the disruption
of replication in rapidly growing cancer, thus affecting
their growth. Reverse transcriptases are also inhibited by
fagaronine (Fleury et al., 2000).
3.10. Glycyrrhiza glabra L.
Glycyrrhiza glabra is commonly known by the name
‘sweetwood’ and belongs to family Fabaceae. The
Mediterranean and certain areas of Asia are its habitat.
It contains an active chemical complex composed of
triterpene saponins, flavonoids, polysaccharides, pectins,
simple sugars, amino acids, mineral salts, and various
other substances (Obolentseva et al., 1999). Important
secondary metabolites glabridin and hispaglabridins
A and B are associated with significant antioxidant
activity, and estrogen-like activity is contributed by
glabridin and glabrene. It has been used against the
human immunodeficiency virus (Hattori et al., 1989),
cytomegalovirus, and herpes simplex virus. The antitumor
activity of the plant is attributed to the metabolite
isoliquiritigenin (2′,4′,4-trihydroxychalcone), which has
shown potential chemopreventive activity through various
mechanisms like induction of phase II enzymes such as
quinone reductase 1, increased expression of glutathione
peroxidase 5, and downregulation of several cytochrome
P450 genes (Cuendet et al., 2010).
3.11. Indigofera tinctoria L.
Indigofera tinctoria belongs to the family Papilionaceae and
is found in most countries of Africa, Australia, and Asia.
It is commonly known as indigo. Phytochemical screening
has shown that the plant contains flavonoids, terpenoids,
alkaloids, and glycosides as its chemical constituents
(Verma and Suresh, 2002). Medicinal benefits of the plant
include treatment of chronic bronchitis, asthma, ulcers,
skin diseases, gastropathy, and epilepsy; it also contributes
to growth of hair and acts as an antidepressant. The
contribution of this plant towards potential antitumor
activity is because of its metabolite indirubin, which has
the ability to inhibit Lewis lung carcinoma (LLC) in mice.
Indirubin is also a potent inhibitor of cyclin-dependent
kinases. Indirubin-3′-monoxime inhibits the proliferation
of a large range of cells, mainly through arresting the cells
in the G2/M phase of the cell cycle. The inhibition of DNA
polymerase I activity and subsequently DNA synthesis
contributes to antitumor activity. Experimental studies in
several cell lines, in cell-free assay, and in rats with Walker
256 sarcoma have shown that indirubin significantly
inhibits DNA synthesis (Hoessel et al., 1999).
3.12. Mangifera indica L.
Mangifera indica belongs to the family Anacardiaceae and
is commonly known as mango. M. indica has its origins
in India and Myanmar and it is the most cultivated
Mangifera species. It has applications as a medication
for gastrointestinal disorders, bilious disorders, blood
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disorders, scurvy, and vitamin A deficiencies (night
blindness). Fresh mango leaves have also been used
for the treatment of diabetes (Shah et al., 2010). In
addition to the above medicinal importance, a recent
study reported the presence of a triterpene called lupeol
in mango fruit that possesses cytotoxic effect against
skin cancer, as it has been shown to induce apoptosis in
human epidermoid carcinoma A431 cells. Apoptosis
is induced in a dose-dependent manner in association
with the caspase-dependent mitochondrial cell death
pathway. It also inhibits the Akt/PKB signaling pathway by
inhibition of Bad (Ser136) phosphorylation. Thus, lupeol
is anticancerous in its ability to inhibit several molecular
targets involved in cancer (Prasad et al., 2009).
3.13. Morinda citrifolia L.
Morinda citrifolia is commercially known by the name
‘noni’ and it is a member of family Rubiaceae. It is native
from Southeast Asia (Indonesia) to Australia. The major
secondary metabolites of this plant are lignans, oligo- and
polysaccharides, iridoids, fatty acids, scopoletin, flavonoids,
catechin, β-sitosterol, damnacanthal, and alkaloids (Wang
et al., 2002). Its pharmacological benefits include use in
treatment for malaria, jaundice, hypertension, boils,
carbuncles, stomach ulcers, stomachache, fractures,
diabetes, loss of appetite, urinary tract ailments, abdominal
swelling, hernias, and human vitamin A deficiency, as
well as use as a general febrifuge and for analgesic effect.
Two unique glycosides, 6-O-(β-D-glucopyranosyl)-1-Ooctanoyl-β-D-glucopyranose and asperulosidic acid, have
been isolated from the noni fruit’s juice and were found
to be highly efficient in inhibiting TPA- or EGF-promoted
cell transformation as well as related AP-1 activity in the
mouse epidermal JB6 cell line (Liu et al., 2001). Increased
AP-1 activity is associated with malignant transformation
and cancer-promoting agents. Thus, the ability to inhibit
AP-1 activity marks the importance of these glycosides as
antitumor agents.
3.14. Newbouldia laevis Seem.
Newbouldia laevis is commonly known as the African
Border tree and belongs to the family Bignoniaceae. It
is used as a therapy against many diseases. Its potential
applications are as a remedy for epilepsy and convulsions
in children, in treatment of rheumatism, and as a
febrifuge. Its extracts have also been shown to exhibit
antimicrobial activity (Kuete et al., 2007) and antimalarial
properties (Eyong et al., 2006). The cytotoxic effect of
the plant is attributed to its compound 2-acetylfuro-1,4naphthoquinone, which induces apoptosis, even without
caspase 3/7 activation. In pancreatic cancer cell lines, it is
known to inhibit the formation of blood capillaries (Kuete
et al., 2011).
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3.15. Nigella sativa L.
Nigella sativa is commonly called ‘black caraway’,
‘black cumin’, or ‘black seed’ and belongs to the family
Ranunculaceae. It is well distributed in Central Asia.
Phytochemical studies have reported the presence of
a number of chemical constituents like nigellicine,
nigellidine,
nigellimine-N-oxide,
thymoquinone,
dithymoquinone,
thymohydroquinone,
nigellone,
thymol, arvacrol, oxy-coumarin, 6-methoxycoumarin
and 7-hydroxycoumarin, α-hedrin, and steryl glucoside,
as well as rich amounts of flavinoids, tannins, essential
fatty acids, essential amino acids, ascorbic acid, iron,
and calcium. Its medicinal values include analgesic,
antiinflammatory, antihistaminic, antiallergic, antioxidant,
anticancer,
immune
stimulation,
antiasthmatic,
antihypertensive, hypoglycemic, antibacterial, antifungal,
antiviral, and antiparasitic effects (Ali and Bluden, 2003).
Thymoquinone, a secondary metabolite of this plant, has
cytotoxic effects as it induces apoptosis in tumor cells
by suppressing NF-κB, Akt activation, and extracellular
signal-regulated kinase signaling pathways; it also inhibits
tumor angiogenesis (Plengsuriyakarn et al., 2012).
3.16. Panax ginseng C.A.Mey.
Panax ginseng is a prevalent perennial herb that belongs to
the family Araliaceae and is commonly known as ginseng.
It is widely found in China, Korea, Japan, Russia, and the
United States. The active chemical components include
a diverse group of steroidal saponins that are known as
ginsenosides (Attele, 1999). It exhibits a multitude of
pharmacological effects including immunomodulatory
and antiinflammatory, and it helps in improvement
of physical stamina, stimulation of the appetite, and
enhancing of learning, memory, and behavior (Sun, 2004).
It is also well known for its adaptogenic effects that help
to improve resistance to stress. Its polyphenol compounds
and saponins contribute to its antitumor potential. The
cytotoxic nature of ginsenosides is clearly shown by their
potential to induce cell death (such as apoptosis and
necrosis), and by their association with antiproliferation,
antiinvasion, and antiangiogenesis properties. Thus,
ginseng is anticancerous in nature (Yue et al., 2007).
3.17. Plumbago zeylanica L.
Plumbago zeylanica is a member of the family
Plumbaginaceae and originated from Southeast Asia. Its
common names are ‘white leadwort’, ‘Ceylon leadwort’,
‘plumbago’, and ‘chitrak’. Chemical screening studies
have shown the presence of a number of secondary
metabolites: plumbagin, coumarins seselin and
suberosin,
2,2-dimethyl-5-hydroxy-6-acetylchromene,
plumbagin acid, β-sitosteryl-glucoside, bakuchiol,
12-hydroxyisobakuchiol,
saponaretin,
isoorientin,
isoaffinetin, and psoralen. Its wide-ranging medicinal
applications include its use in treatment of fever and

malaria, diarrhea, piles, dyspepsia, skin diseases (leprotic
lesions) (Gupta et al., 1993), gastrointestinal complaints
(Giday et al., 2006), ulcers, and scabies. Plumbagin, a
quinoid isolated from the plant’s root, has been shown to
possess antitumor activity by potential effects in the control
of hormone-refractory invasive prostate cancer (PCa).
The inhibitory effects of plumbagin against a number of
molecular targets like protein kinase C epsilon (a PCa
proliferative marker), STAT-3, AKT, and PI-3K result in
the inhibition of growth and invasion of PCa. Plumbagin,
in addition to inhibiting growth of cancer cells, also
induces apoptosis in cancer cells (Aziz et al., 2008).
3.18. Rhinacanthus nasutus (L.) Kurz
Rhinacanthus nasutus belongs to the family Acanthaceae
and is widely distributed in parts of subcontinental
India and in Southeast Asia and China (Rao et al.,
2010). The plant is commonly known by the name
‘snake jasmine’. Naphthoquinone, rhinacanthins (A–D,
G–Q), rhinacanthone, and lignan groups are the major
phytochemical compounds of this plant (Thirumurugan
et al., 2000). Pharmacological benefits attributed to
its active constituents include treatment of eczema,
pulmonary tuberculosis, herpes, hepatitis, diabetes,
hypertension, and various skin diseases. Studies have
suggested that rhinacanthins M, N, and Q and related
naphthoquinone esters as well as synthetic compounds,
1,2-naphthoquinones and 1,4-naphthoquinones, are
antitumorous as they selectively inhibit the growth of
KB, HeLa, and HepG2 human cancer cells and normal
Vero cells. The partial arrest of cells at the G2/M
phase in rhinacanthin N treatment has been observed
experimentally, which helped to prevent further damage
and gave cells the time to repair the defect or undergo
apoptosis (Siripong et al., 2006).
3.19. Scutellaria baicalensis Georgi
Scutellaria baicalensis belongs to the family Lamiaceae.
It is native to eastern Asia and has major applications
in traditional Chinese medicine. Its common names
are ‘Chinese skullcap’, ‘baikal’, ‘scute’, and ‘scutellaria’.
Root extracts of this plant contain almost 70 flavonoids,
anthocyanidins, chalcones, flavanonols, flavonols,
flavanones, and flavones. The pharmacological effects of this
plant include antidiabetic, antiinflammatory, antioxidative,
hepatoprotective, antiviral, antianxiety, antitumor,
and antihypertensive effects (Bhandari et al., 2010). Its
antitumor activity is attributed to baicalein, wogonin,
wogonoside, and skullcapflavone II (neobaicalein). All
these metabolites at micromolar concentrations have
shown inhibitory effects against the proliferation of
human tumor cell lines LXFL and 529L (large-cell lung
carcinomas). Baicalein inhibits 12-lipoxygenase activity
and contributes to anticancer potential against a number
of other cancers, also. The inhibition of 12-lipoxygenase
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activity acts as interference in the signaling mechanism
needed for tumor growth (Zhou et al., 2008).
3.20. Solanum incanum L.
The geographical habitat of Solanum incanum, a member of
the family Solanaceae (nightshade plants), is the temperate
and tropical regions of the world. The plant is commonly
known by the names ‘bitter apple’ and ‘thorn apple’.
The main chemical constituents of the plant are steroid
glycosides, which are known to possess defensive role
against pathogens and predators of the plant. Solanin and
solasonine are steroid alkaloids, which have applications
against cutaneous mycotic infections and other infectious
conditions (Al-Fatimi et al., 2007). Another metabolite,
solamargine, is known to have cytotoxic activity towards
normal skin fibroblasts by its ability to induce cell
apoptosis. The cytotoxic effects of solamargine have been
experimentally studied in 4 human lung cancer cell lines.
The molecular effects of this metabolite that clearly validate
its potential as an anticancer agent for tumor necrosis
factors and Bcl-2-related resistance of human lung cancer
cells include the release of cytochrome c, downregulation
of antiapoptotic Bcl-2 and Bcl-xL, increase of caspase-3
activity (important for apoptosis), and DNA fragmentation
(Liu et al., 2004).
3.21. Vismia laurentii De Wild.
Vismia laurentii belongs to the family Guttiferae and is
widely distributed in the tropical and subtropical regions
of the world. There is no English common name for this
plant. Chemical studies have reported the presence of
xanthones, anthraquinones, and prenylated anthrones in
this plant. Recently, in a systematic search for new bioactive
lead structures, 1 new xanthone, laurentixanthone C,
and 3 known compounds identified as vismiaquinone,
bisvismiaquinone, and dammaradienol were isolated from
V. laurentii (Hussain et al., 2012). It is used as a remedy
for the treatment of skin diseases (such as dermatitis,
leprosy, scabies, and eczema) and wounds. Experimental
studies suggesting the anticancer potential of xanthone V1
have already been done in a number of cancer cell lines.
The effects of xanthone V1 on the cell cycle distribution,
apoptosis induction, and caspase-3/7 activity have been
investigated in the CCRF-CEM cell line and show evidence
for its anticancer potential as a cytotoxic agent. Xanthone
V1 leads to activation of caspase-3/7 enzymes, which play
important roles as apoptosis inducers (Kuete et al., 2011).
3.22. Withania somnifera (L.) Dunal
Withania somnifera is a minor, timbered shrub in the
family Solanaceae that is commonly known as ashwaganda.
It is found in Africa, the Mediterranean, and India. The
major biochemical constituents are steroidal alkaloids and
steroidal lactones, and as a class of constituents, they are
called withanolides. Therapeutic values associated with
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this plant are adaptogen, aphrodisiac, antiinflammatory,
deobstruent, antibiotic, diuretic, narcotic, sedative,
abortifacient, immune system-stimulating, astringent,
and antioxidant effects (Singh et al., 2010). The antitumor
property of the plant is well defined by the fact that
withaferin A, a chemical constituent of this medicinal
plant, inhibits growth of MDA-MB-231 and MCF-7
human breast cancer cells and MDA-MB-231 xenografts
in vivo, in association with apoptosis induction mediated
by reactive oxygen species production due to the inhibition
of mitochondrial respiration (Hahm et al., 2011).
3.23. Xanthium strumarium L.
The genus Xanthium is a member of the family Asteraceae,
comprising 25 species of American origin (Oudhia, 2001).
X. strumarium is commonly known as ‘cocklebur’ or
‘burweed’. In India it is well known for its use as a remedy in
hemicrania diseases (Kamboj and Saluja, 2010). Its healthpromoting benefits include antitumor, antibacterial,
antifungal, antiinflammatory, antinociceptive, antitussive,
hypoglycemic, antimitotic, antitrypanosomal, antimalarial,
diuretic, antioxidant, analgesic, repellent, and insecticidal
activities. Its metabolite, 8-epi-xanthatin, and its epoxide
show strong evidence of being antitumorous as they
significantly inhibit the proliferation of cultured human
tumor cell lines. 8-epi-Xanthatin acts by farnesyltransferase
inhibitory effect and also inhibits microtubule-interfering
agents. These inhibitions contribute to the anticancer
activity of 8-epi-xanthatin (Kim et al., 2003).
3.24. Zanthoxylum nitidum (Roxb.)
Zanthoxylum nitidum belongs to the family Rutaceae
and is widely distributed in Southeast Asian countries
and Australia (Hu et al., 2007). It is commonly known
by the name ‘prickly ash’. The presence of true alkaloids,
carbohydrates, flavonoids, and amino acids has been
revealed by phytochemical studies (Bhattacharya
and Zaman, 2009). Nitidine chloride, oxynitidine,
dihydronitidine,
6-methoxy-5,6-dihydrochelerythrine,
α-allocryptopine, and skimmianine are the main alkaloids
isolated from its roots. The medical application of the
plant includes the cure of toothache, stomachache,
fever, rheumatism, paresis, boils, cough, colic, vomiting,
diarrhea, and cholera. The anticancer potential of the
plant is attributed to the chemical constituent nitidine,
known for its ability to exhibit cytotoxic activity against
LLC. It is a DNA intercalator that is generally classified
as an inhibitor of topoisomerases I and II. The inhibition
of these enzymes leads to subsequent apoptosis in cancer
cells (Fang et al., 1993).
4. Discussion
Medicinal plants have contributed richly to the health
of human beings. The vast potential of plant-based
medicines in the treatment of numerous diseases has
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always contributed to the value of the plant community as
a major area of research and development. Chemotherapy
is an important option in modern cancer treatment, and
plant-derived chemotherapeutic agents have contributed
greatly to the progress of oncology/chemotherapy
development and to clinical practice. The need to cure
cancer and find better ways to combat this disease has
raised the need to find anticancer compounds in the plant
kingdom. Plant extracts and the bioactive compounds
present in them, which are responsible for anticancer
activity, have to be screened for valuable information.
Innovations in multidisciplinary investigative methods
offer great promise for plant-derived drug discovery and
development. This review includes medicinal plants with
chemical constituents that possess anticancer properties.
Most of the plant compounds described in this review
are antitumorous, as explained by in vitro studies. Some
of their metabolites are cytotoxic in nature, with the
ability to induce apoptosis in cancer cells; this includes
Andrographis paniculata, Centella asiatica, Newbouldia
laevis, Nigella sativa, Panax ginseng, Plumbago zeylanica,
Solanum incanum, and Vismia laurentii. According to
the International Union for the Conservation of Nature’s
Red List of Threatened Species (www.iucnredlist.org.),
the most comprehensive inventory for the conservation
status of biological species, most of the above-mentioned
plants have not yet been evaluated for their conservation
status, except for C. asiatica and M. indica, whose status
is “Least Concern” and “Data Deficient”, respectively. In

addition, the medicinal plants mentioned here are not
confined to a particular geographical region; rather, they
are diversely present across various regions of the world.
In vitro studies have revealed the anticancer potential
of the metabolites discussed in this review, so they hold
scope for further experimentations. The plant metabolites
mentioned in this review possess varying mechanisms of
action that contribute to their anticancer nature. Some
metabolites work by selectively killing the rapidly dividing
cancer cells, while others target molecular factors (mostly
proteins) that are abnormally expressed in cancer cells.
The cytotoxicity of cancer cells is induced by impairing the
cell cycle (mitosis) at certain stages and also by promoting
molecular factors responsible for apoptosis (increase of
caspase-3/7, down regulation of Bcl-2, etc.). The antitumor
effect of certain metabolites is observed in their ability
to inhibit abnormally expressed growth factors (mostly
protein tyrosine kinase) and thus inhibit the growth of
cancer cells. The anticancer metabolites mentioned in
this review can be further researched based on prior
toxicological investigations to develop them as anticancer
drugs. In the process of drug development, they can be
subjected to clinical trials to account for their safety and
effectiveness. Therefore, in the present review, an effort
has been made to compile information about some of the
plants possessing anticancer activity for various types of
cancer. This review can help others to explore herbs to
further extend and promote the use of medicinal plants as
potential tools to treat cancer.

References
Akter R, Uddin SJ, Grice ID, Tiralongo D (2014). Cytotoxic activity
screening of Bangladeshi medicinal plant extracts. J Nat Med
68: 246–252.
Al-Fatimi M, Wurster M, Schroder G, Lindequist U (2007).
Antioxidant, antimicrobial and cytotoxic activities of selected
medicinal plants from Yemen. J Ethnopharmacol 111: 657–666.
Ali BH, Blunden G (2003). Pharmacological and toxicological
properties of Nigella sativa. Phytother Res 17: 299–305.
Alonso-Castro AJ, Villarreal ML, Salazar-Olivo LA, Gomez-Sanchez
M, Dominguez F, Garcia-Carranca A (2011). Mexican
medicinal plants used for cancer treatment: Pharmacological,
phytochemical and ethnobotanical studies. J Ethnopharmacol
133: 945–972.
Ammon HPT, Anazodo MI, Safayhi H, Dhawan BN, Srimal RC
(1992). Curcumin: a potent inhibitor of leukotriene B4
formation in rat peritoneal polymorphonuclear neutrophils
(PMNL). Planta Med 58: 226.
Attele AS, Wu JA, Yuan CS (1999). Ginseng pharmacology: multiple
constituents and multiple actions. Biochem Pharmacol 58:
1685–1693.

Aziz MH, Dreckschmidt NE, Verma AK (2008). Plumbagin, a
medicinal plant-derived naphthoquinone, is a novel inhibitor
of the growth and invasion of hormone-refractory prostate
cancer. Cancer Res 68: 9024–9032.
Belayachi L, Aceves-Luquero C, Merghoub N, Bakri Y, de Mattos
SF, Amzazi S, Villalonga P (2013). Screening of North African
medicinal plant extracts for cytotoxic activity against tumor
cell lines. Eur J Med Plants 3: 310–332.
Bhandari M, Bhandari A, Prakash R, Bhandari A (2010). Scutellaria
baicalensis Georgi: a rising paradigm of herbal remedies.
Pharmaceutical Sci 1: WMC001105.
Bhatnagar SS, Santapau H, Desa JD, Maniar AC, Ghadially NC,
Solomon MJ, Yellore S, Rao TN (1961). Biological activity of
Indian medicinal plants. I. Antibacterial, antitubercular and
antifungal action. Indian J Med Res 49: 799–813.
Bhattacharya S, Zaman MK (2009). Pharmacognostical evaluation
of Zanthoxylum nitidum bark. Int J PharmTech Res 1: 292–298.
Cassileth BR, Deng G (2004). Complementary and alternative
therapies for cancer. Oncologist 9: 80–89.

1033

RAINA et al. / Turk J Bot
Cuendet M, Guo J, Luo Y, Chen S, Oteham CP, Moon RC, Breemen
RBV, Marler LE, Pezzuto JM (2010). Cancer chemopreventive
activity and metabolism of isoliquiritigenin, a compound
found in licorice. Cancer Prev Res (Phila) 3: 221–232.
Einbonda LS, Soffritti M, Esposti DD, Park T, Cruz E, Su T, Wu HA,
Wang X, Zhang YJ, Ham J et al. (2009). Actein activates stressand statin-associated responses and is bioavailable in SpragueDawley rats. Fund Clin Pharmacol 23: 311–321.
Eyong KO, Folefoc GN, Kuete V, Beng VP, Krohn K, Hussain
H, Nkengfack AE, Saeftel M, Sarite SR, Hoerauf A (2006).
Newbouldiaquinone A: a naphthoquinone-anthraquinone
ether coupled pigment, as a potential antimicrobial and
antimalarial agent from Newbouldia laevis. Phytochemistry 67:
605–609.
Fang SD, Wang LK, Hecht SM (1993). Inhibitors of DNA
topoisomerase I isolated from the roots of Zanthoxylum
nitidum. J Org Chem 58: 5025–5027.
Fleury F, Sukhanova A, Ianoul A, Devy J, Kudelina I, Duval O, Alix
AJ, Jardillier JC, Nabiev I (2000). Molecular determinants of
site-specific inhibition of human DNA topoisomerase I by
fagaronine and ethoxidine. Relation to DNA binding. J Biol
Chem 275: 3501–3509.
Gerson-Cwilich R, Serrano-Olvera A, Villalobos-Prieto A (2006).
Complementary and alternative medicine (CAM) in Mexican
patients with cancer. Clin Transl Oncol 8: 200–207.
Giday M, Teklehaymanot T, Animut A, Mekonnen Y (2006).
Medicinal plants of the Shinasa, Agewawi and Amhara people
in Northwest Ethiopia. J Ethnopharmacol 110: 516–525.
Gordaliza M (2007). Natural products as leads to anticancer drugs.
Clin Transl Oncol 9: 767–776.
Gupta MM, Verma RK, Uniyal GC, Jain SP (1993). Determination
of plumbagin by normal-phase high-performance liquid
chromatography. J Chromatogr A 637: 209–212.
Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S, Singh
SV (2011). Withaferin A-induced apoptosis in human breast
cancer cells is mediated by reactive oxygen species. PLoS One
6: e23354.
Hattori T, Ikematsu S, Koito A, Matsushita S, Maeda Y, Hada M,
Fujimaki M, Takatsuki K (1989). Preliminary evidence for
inhibitory effect of glycyrrhizin on HIV replication in patients
with AIDS. Antiviral Res 11: 255–261.
Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost
M, Damiens E, Marie D, Marko D et al. (1999). Indirubin, the
active constituent of a Chinese antileukaemia medicine, inhibits
cyclin dependent kinases. Nature Cell Biol 1: 60–67.
Horgen FD, Guinaudeau H, Pezzuto JM, Soejarto DD, Farnsworth
NR, Agcaoili F, de los Reyes G, Edrada RA (1997). Isolation and
structure elucidation of ardisenone a new, cytotoxic alkenylphenol
from Ardisia iwahigensis. J Nat Prod 60: 533–535.
Hu J, Zhang WD, Shen YH, Zhang C, Xu L, Liu RH, Wang B, Xu XK
(2007). Alkaloids from Zanthoxylum nitidum (Roxb.) DC.
Biochem Syst Ecol 35: 114–117.

1034

Hussain H, Hussain J, Al-Harrasi A, Saleem M, Green IR, van Ree
T, Ghulam A (2012). Chemistry and biology of genus Vismia.
Pharm Biol 50: 1448–1462.
Ip C, Lisk DJ (1996). The attributes of selenium-enriched garlic in
cancer prevention. Adv Exp Med Biol 401: 179–187.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global
Cancer Statistics. CA Cancer J Clin 61: 69–90.
Ji L, Liu T, Liu J, Chen Y, Wang Z (2007). Andrographolide inhibits
human hepatoma-derived Hep3B cell growth through the
activation of c-Jun N-terminal kinase. Planta Med 73: 1397–1401.
Kamboj A, Saluja AK (2010). Phytopharmacological review of
Xanthium strumarium L. (cocklebur). International Journal of
Green Pharmacy 4: 129–139.
Kim YS, Kim JS, Park SH, Choi SU, Lee CO, Kim SK, Kim YK, Kim
SH, Ryu SY (2003). Two cytotoxic sesquiterpene lactones from
the leaves of Xanthium strumarium and their in vitro inhibitory
activity on farnesyltransferase. Planta Med 69: 375–377.
Krieglstein CF, Anthoni C, Rijcken EJ, Laukötter M, Spiegel HU, Boden
SE, Schweizer S, Safayhi H, Senninger N, Schürmann G (2001).
Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal
medicine from Boswellia serrata resin, attenuates experimental
ileitis. Int J Colorectal Dis 16: 88–95.
Kuete V, Eyong KO, Folefoc GN, Beng VP, Hussain H, Krohn K,
Nkengfack AE (2007). Antimicrobial activity of the methanolic
extract and of the chemical constituents isolated from Newbouldia
laevis. Pharmazie 62: 552–556.
Kuete V, Wabo HK, Eyong KO, Feussi MT, Wiench B, Krusche B, Tane P,
Folefoc GN, Efferth T (2011). Anticancer activities of six selected
natural compounds of some Cameroonian medicinal plants.
PLoS One 6: e21762.
Lee YS, Jin DQ, Kwon EJ, Park SH, Lee ES, Jeong TC, Nam DH, Huh
K, Kim JA (2002). Asiatic acid, a triterpene, induces apoptosis
through intracellular Ca2+ release and enhanced expression of p53
in HepG2 human hepatoma cells. Cancer Lett 186: 83–91.
Li M, Wei SY, Xu B, Guo W, Liu DL, Cui JR, Yao XS (2008). Proapoptotic and microtubule-disassembly effects of ardisiacrispin
(A+B), triterpenoid saponins from Ardisia crenata on human
hepatoma Bel-7402 cells. J Asian Nat Prod Res 10: 729–736.
Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z (2001). Two novel
glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1
transactivation and cell transformation in the mouse epidermal
JB6 cell line. Cancer Res 61: 5749–5756.
Liu LF, Liang CH, Shiu LH, Lin WL, Lin CH, Kuo KW (2004). Action
of solamargine on human lung cancer cells--enhancement of
the susceptibility of cancer cells to TNFs. FEBS Lett 577: 67–74.
Mahady GB, Fabricant D, Chadwick LR, Dietz B (2002). Black
cohosh: an alternative therapy for menopause? Nutr Clin Care
5: 283–289.
Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E,
Browall M, Fernandez Ortega P, Pud D, Margulies A (2006).
Complementary and alternative medicine use in lung cancer
patients in eight European countries. Complement Ther Clin
Pract 12: 34–39.

RAINA et al. / Turk J Bot
Nema R, Khare S, Jain P, Pradhan A, Gupta A, Singh D (2013).
Natural products potential and scope for modern cancer
research. Am J Plant Sci 4: 1270–1277.
Noble RL (1990). The discovery of the vinca alkaloids-chemotherapeutic agents against cancer. Biochem Cell Biol 68:
1344–1351.
Obolentseva GV, Litvinenko VI, Ammosov AS, Popova TS, Sampiev
AM (1999). Pharmacological and therapeutic properties of
licorice preparations (a review). Pharm Chem J 33: 24–31.
Oudhia P (2001). Phyto-sociological studies of rainy season wasteland
weeds with special reference to Parthenium hysterophorus
L. in Raipur (India) district. Asian Journal of Microbiology,
Biotechnology and Environmental Sciences 3: 89–92.
Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu
M (2009). Acetyl-11-keto-b-boswellic acid inhibits prostate
tumor growth by suppressing vascular endothelial growth
factor receptor 2-mediated angiogenesis. Cancer Res 69: 5893–
5900.
Plengsuriyakarn T, Viyanant V, Eursitthichai V, Picha P, Kupradinun
P, Itharat A, Na-Bangchang K (2012). Anticancer activities
against cholangiocarcinoma, toxicity and pharmacological
activities of Thai medicinal plants in animal models. BMC
Complement Altern Med 12: 23.
Prasad S, Madan E, Nigam N, Roy P, George J, Shukla Y (2009).
Induction of apoptosis by lupeol in human epidermoid
carcinoma A431 cells through regulation of mitochondrial,
Akt/PKB and NFkB signaling pathways. Cancer Biol Ther 8:
1632–1639.

Shah KA, Patel MB, Patel RJ, Parmar PK (2010). Mangifera indica
(mango). Pharmacogn Rev 4: 42–48.
Sigounas G, Hooker J, Anagnostou A, Steiner M (1997).
S-Allylmercaptocysteine inhibits cell proliferation and reduces
the viability of erythroleukemia, breast, and prostate cancer
cell lines. Nutr Cancer 27: 186–191.
Singh G, Sharma PK, Dudhe R, Singh S (2010). Biological activities
of Withania somnifera. Ann Biol Res 1: 56–63.
Siripong P, Yahuafai J, Shimizu K, Ichikawa K, Yonezawa S, Asai T,
Kanokmedakul K, Ruchirawat S, Oku N (2006). Antitumor
activity of liposomal naphthoquinone esters isolated from Thai
medicinal plant: Rhinacanthus nasutus Kurz. Biol Pharma Bull
29: 2279–2283.
Sun LQ (2004). Information on research and application of Ginseng,
the king of traditional and herbal medicines. Asian Journal of
Drug Metabolism and Pharmacokinetics 4: 264–282.
Tascilar M, De Jong FA, Verweij J, Mathijssen RH (2006).
Complementary and alternative medicine during cancer
treatment: beyond innocence. Oncologist 11: 732–741.
Thirumurugan RS, Kavimani S, Srivastava RS (2000). Anti-tumour
activity of rhinacanthone against Dalton’s ascitic lymphoma.
Biol Pharma Bull 23: 1438–1440.
Verma SM, Suresh KB (2002). Phytochemical investigation of
Indigofera tinctoria Linn leaves. Anc Sci Life 21: 235–239.
Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK, Anderson G
(2002). Morinda citrifolia (noni): a literature review and recent
advances in noni research. Acta Pharmacol Sin 23: 1127–1141.

Rao PV, Goudu S, Sasikala S, Naidu MD (2010). Efficacy of
antimicrobial activity of Rhinacanthus nasutus (Linn) leaves in
different extractions. International Journal of Pharma and Bio
Sciences 1: 1–4.

Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT, Yeung
HW, Wong RN (2007). Pharmacogenomics and the Yin/Yang
actions of ginseng: antitumor, angiomodulating and steroidlike activities of ginsenosides. Chinese Med 2: 6.

Saklani A, Kutty SK (2008). Plant-derived compounds in clinical
trials. Drug Discov Today 13: 161–171.

Zhou Y, Gao W, Li K (2008). Chinese herbal medicine in the
treatment of lung cancer. Asian J Tradit Med 3: 1–11.

1035

